Product Information
TEMAZEPAM 7.5 MG CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $0.9116 per EA under NDC 43547061110. Its NADAC has been published 150 times since Aug 16, 2023.
Strength
7.5 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547061110
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA201781On Market Since
1/5/2023
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 7.5 MG CAPSULE has been published 150 times since Aug 16, 2023, and over the history we have for it it has risen 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9116 per EA |
|---|---|
| All-time high | $1.5515 (Apr 10, 2024) |
| All-time low | $0.7393 (Nov 20, 2024) |
| 52-week high | $0.9430 |
| 52-week low | $0.7894 |
| Median price | $0.9430 |
| Average price | $1.0228 |
| Largest weekly change | +51.7% (Aug 21, 2024) |
| Weeks tracked | 150 |
| Tracking since | Aug 16, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 7.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 7.5 MG CAPSULE, manufactured by Solco Healthcare US LLC, is $0.9116 per EA (NDC 43547061110), effective Jun 24, 2026.
How has the price of TEMAZEPAM 7.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has risen 12.1%. It has been tracked across 150 weekly CMS publications since Aug 16, 2023.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 7.5 MG CAPSULE?
Since Aug 16, 2023, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has ranged from a low of $0.7393 (Nov 20, 2024) to a high of $1.5515 (Apr 10, 2024), with a median of $0.9430 per EA.
Are there cheaper alternatives to TEMAZEPAM 7.5 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TEMAZEPAM 7.5 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMAZEPAM 7.5 MG CAPSULE?
TEMAZEPAM 7.5 MG CAPSULE (NDC 43547061110) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification